Press "Enter" to skip to content

New patent for Galderma Labs drug AKLIEF

0
Copyright © DrugPatentWatch. Originally published at New patent for Galderma Labs drug AKLIEF

Annual Drug Patent Expirations for AKLIEF
Annual Drug Patent Expirations for AKLIEF

Aklief is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

AKLIEF drug price trends.

This drug has forty-two patent family members in twenty-six countries.

The generic ingredient in AKLIEF is trifarotene. One supplier is listed for this compound. Additional details are available on the trifarotene profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Galderma Labs drug AKLIEF
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions